Clinical Trial Update: Effect of Quetiapine on Negative Symptoms and Cognition [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating quetiapine for negative symptoms and cognition in schizophrenia has completed. The entry notes the study status as completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED